Taiwan FDA registration 1c14aa908b928eccc721d9fd88645ee7
"Siemens" thyroglobulin test reagent
TW: “西門子” 甲狀腺球蛋白檢驗試劑
Taiwan·Risk Class 2·SIEMENS HEALTHCARE DIAGNOSTICS INC.·Registered Jul 28, 2023 – Jul 28, 2028ActiveRegistration details
- Analysis ID
- 1c14aa908b928eccc721d9fd88645ee7
- Customs Code
- DHA05603620608
Company information
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS INC.
- Manufacturer Country
- United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
Product details
- Intended Use
- This product is intended for in vitro diagnostic use and is used with the Atellica IM Analyzer for the quantitative detection of thyroglobulin in human serum and plasma (EDTA and lithium heparin).
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.6010 腫瘤相關抗原免疫試驗系統
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Jul 28, 2023
- Expiry Date
- Jul 28, 2028
About this record
Access comprehensive regulatory information for "Siemens" thyroglobulin test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1c14aa908b928eccc721d9fd88645ee7 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices